ECM Weekly (20 Oct 2019) - China Feihe, Metro Pac Hospital, Onsite Rental, CMGE Tech

400 Views20 Oct 2019 09:57

Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for upcoming IPOs.

This week, we welcome Ming LU to the Aequitas Research team with his debut on-the-ground research on China Feihe (FEIHE HK)'s upcoming IPO! He visited a local supermarket and shared his thoughts on Feihe's product and the local sentiment. Ming Lu will continue to cover China tech companies and work closely with us

Complementing Ming Lu's research, Ke Yan, CFA, FRM looked at the company from a quantitative perspective, comparing it with peers, and gave his thoughts on valuation.

Overall, Hong Kong IPOs are going full steam ahead in Q4. Languang Justbon Services (2606 HK) closed 15% above its IPO price on debut (way better than our expectation), riding on positive sentiment of recently listed smaller IPOs and the general outperformance of the HK-listed property management companies of late.

We are also hearing that JS Global Lifestyle (JSG HK) and ESR Cayman (ESR HK) will launch their bookbuilds on Monday. JSG is looking to raise about US$400 - 500m while ESR is likely launching a US$1.3bn deal size with about the same deal size as before (in June). Other than that, CMGE Tech (CMGE HK) launched its US$166m IPO bookbuild this week with some interesting cornerstone investors and we heard that books were already covered. Megvii is also said to be targeting to list by the end of the year despite the recent U.S. blacklist souring sentiment.

In the Philippines, Metro Pacific Hospital Holdings Inc (HOSP PM) which was stipulated to list in November, put its IPO on hold just when we published our early thoughts on valuation the same day. The company sold about 42.5% stake to a KKR-led consortium. ECM in the country is looking active with Cal-Comp Tech (Philippines) (CCTP PH) being approved for a US$180m IPO up from its earlier expected deal size of US$120m.

In Australia, unlike other countries, momentum has yet to build up despite the pipeline of IPOs coming to the market. Latitude Financial Services (1272471D AU) was pulled even after cutting its IPO price by 11% ahead of its bookbuild. Valuation was still expensive compared to peers like FlexiGroup. So far, we have yet to hear anything ahead of PropertyGuru (PGU AH) bookbuild but Onsite Rental (ONSITE AU) is already prepping up for its IPO.

In India, we are hearing that SAMHI Hotels is pre-marketing its US$350m IPO and looking to launch Q1 2020 and Equitas Holdings Ltd/India (EQUITAS IN) appointed JM Financial, IIFL and Edelweiss Financial, for the Equitas Small Finance Bank’s IPO.

Accuracy Rate:

Our overall accuracy rate is 72.7% for IPOs and 64.9% for Placements

(Performance measurement criteria is explained at the end of the note)

New IPO filings this week

  • Innocare Pharma (Hong Kong, US$200m)

Below is a snippet of our IPO tool showing upcoming events for the next week. The IPO tool is designed to provide readers with timely information on all IPO related events (Book open/closing, listing, initiation, lock-up expiry, etc) for all the deals that we have worked on. You can access the tool here or through the tools menu.

Source: Aequitas Research, Smartkarma

News on Upcoming IPOs

Analysis on Upcoming IPOs

Hong Kong

Alibaba IPO/Secondary Listing - The Real IPO Only Begins on the 11th Day Post Listing


Alphamab (康宁杰瑞) IPO: Strong R&D Capability and Innovative Platforms

AscentageAscentage Pharma (亚盛医药) IPO: Too Early for an IPO

Ascentage Pharma (亚盛医药) IPO: Updates and Thoughts on HQP1351 (3rd Gen Bcr-Abl TKI)


Ascentage Pharma (亚盛医药) IPO: Some Issues with Banker Forecasts

Ant FinancialAnt Financial IPO Early Thought: Understand Fintech Empire, Growth & Risk Factors

ByteDance (字节跳动) IPO: How Jinri Toutiao Paves The Way for a Bigger Empire (Part 1)


ByteDance (字节跳动) IPO: Tiktok the No.1 Short Video App for a Good Reason (Part 2)


ByteDance (字节跳动) Pre-IPO: How Has It Done in 1H?


ByteDance: The Unlisted Company’s Video Apps Leading the Market and Threatening Internet Giants


Clarity Medical (清晰医疗) IPO: Proxy to HK SMILE Surgery Demand

Broad Home

Changsha Broad Homes IPO - Exposure to Prefabricated Construction in China

China Feihe

China Feihe (中国飞鹤) IPO: New Numbers, New Red Flag, and Demographic Risk

China Feihe

China Feihe (中国飞鹤) IPO: Thoughts on Valuation


Helenbergh (海伦堡) Early Thoughts - The Usual Red Flag - Related Party Transactions

Home Credit

Home Credit Pre-IPO (Part I) - The Positives - Lots to Like

Home Credit

Home Credit Pre-IPO (Part II) - The Negatives - A Lot More to Dislike

Home Credit

Home Credit Pre-IPO - Bigger but Not Necessarily Better than Peers

Home Credit

Home Credit Pre-IPO - Thoughts on Valuation and the Curious Case of Expanding Equity Base


Huali University (华立大学) IPO Early Thoughts - Risks Abound

Hut Chi-Med

Hutchison-China Med (和黄医药) H-Share Listing: MNC Partnerships Endorsed Its R&D Capabilities


Jiumaojiu (九毛九) Pre-IPO Early Thoughts - New Brand Driving Growth

JS Global

JS Global Lifestyle (JS 环球生活) Early Thoughts - Declaring US$470m Dividend Before IPO

JS Global

JS Global Lifestyle (JS 环球生活) Quick Note - Questions About Corporate Structure & Reorganization

JS Global

JS Global Lifestyle (JS 环球生活) Pre-IPO Review - Sometimes, Two Negatives Don't Make a Positive

JS Global

JS Global (JS 环球生活) PHIP & Thoughts on Valuation - Paid a Premium for a Good Brand

MegviiMegvii (旷视) Pre-IPO - Remarkable Growth (Part 1)
MegviiMegvii (旷视) Pre-IPO - A Bet on the Future - Segments, Revenue Drivers and Growth Potential
MegviiMegvii (旷视) Pre-IPO - The Real Race Is in Research - Founders' Profile and Talent
MicuRxMicuRx Pharma (盟科医药) IPO: Betting on Single Drug in the Not so Attractive Antibiotic Segment
PharmaronPharmaron (康龙化成) A+H Listing: A Leading Drug Discovery Company
Poly PrpPoly Property Development (保利物业发展) IPO Early Thoughts - Well-Rounded Company

Renrui Human Resources (人瑞人才) Pre-IPO Review - Riding on China's Unicorns


SinoMab (中国抗体): Pipeline Concentrated on Autoimmune Therapy


Smoore Tech (麦克韦尔) IPO: Hidden E-Cigarette Player Behind the FEELM Technology


Smoore Tech (麦克韦尔) Pre-IPO: 6Y and 1H2019 Financials Show Technology Driven Growth

TaslyTasly Biopharm (天士力生物) IPO: Visible Growth from Approved Drug but Lacks Blockbusters
TOT BioTOT Biopharm (东曜药业) IPO: An Unimpressive Pipeline
TOT BioTOT Biopharm (东曜药业) IPO: Valuation of Core Product TAB008, a Bevacizumab Biosimilar
VenusVenus Medtech (启明医疗) IPO: Has the Elements for a Hot Healthcare Deal
VenusVenus Medtech (启明医疗) IPO: Technical Comparison of VenusA-Valve and Peers
ASKASK Investment Managers Pre-IPO - Riding on a Wave of Wealth
Aakash EduAakash Education Pre-IPO - Fast Growth in an Attractive Sector
Anmol IndAnmol Industries Pre-IPO Quick Take - No Growth, Generous Payments to Founders
Bharat Hotels

Bharat Hotels Pre-IPO - Catching up with Peers

Bajaj En

Bajaj Energy Pre-IPO - Supposed to Deliver Steady Performance if Only Its Sole Client Would Let It

CMS InfoCMS Info Systems Pre-IPO - When a PE Sells to Another PE... Only One Gets the Timing Right
Crystal CropCrystal Crop Protection Pre-IPO - DRHP Raises More Questions than in Answers
Flemingo Flemingo Travel Retail Pre-IPO - Its a Different Business in Every Country
Emami CemEmami Cement Pre-IPO - Still in Ramp Up Phase but Emami Shares Pledge Might Lead to an Early IPO
NSENSE IPO Preview- Not Only Fast..its Risky and Expensive
NSENational Stock Exchange Pre-IPO Review - Bigger, Better, Stronger but a Little Too Fast for Some
MazagonMazagon Dock IPO Preview: A Monopoly Submarine Yard in India with Captive Navy Spending
Mrs. BectorMrs. Bectors Food Specialities Pre-IPO Quick Take - Sales for Its Main Segment Have Been Sta


Lodha Developers Pre-IPO - Second Time Lucky but Not Really that Much Affordable
LodhaLodha Developers IPO: Presence in Affordable Segment Saves Lodha the Blushes in a Sluggish Mkt
Penna CemPenna Cement - Aggressive Expansion Plans Even Though Past Performance Has Been Tepid
PNB MetPNB Metlife Pre-IPO Quick Take - Doesn't Stack up Well Versus Its Larger Peers
UjjivanUjjivan Small Finance Bank Pre-IPO - Shouldn't Be Forced to List
QSRQSR Brands Pre-IPO - As Healthy as Fast Food
The U.S
36Kr36Kr (36氪) IPO: A Specialized Media Company Struggling to Monetize
CloudMindsCloudMinds Inc Early Thoughts - Still Nascent
EcmohoEcmoho (易恒健康) Pre-IPO Review - More Like a Middleman
FangDDFangDD (房多多) IPO: Reminiscence of SFUN?
HuizeHuize (慧择) Pre-IPO - Insurance Agency Masquerading as a Platform Business
MetenMeten International Edu (美联国际教育) Early Thoughts - Unclear Strategies
YoudaoYoudao, Inc (有道) Pre-IPO - Weak Conversion Rate Is a Worry
Q&KQ&K Intl (青客) IPO: Yet Another WeWork Model that Will Not Work
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
  • Unlock all research summaries
  • Follow top, independent analysts
  • Receive personalised alerts and emails
  • Access Briefings, Analytics, and Events

Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.

Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.

Already have an account? Sign In Now
(Paid Plans Only)